Hang in there mate. I think the next 3 months will show a clearer path.
Once CFDA comes through, its game on
NASDAQ raising should see china factory filled with components to kick start manufacturing for the CFDA approval in advance
UK will be the surprise one that will open the door and provide added value to the company.
At the end of the day we have achieved a lot as a start up company and while the sp can be frustrating for those who paid a higher price, the growth in going world wide with products and a well managed team is never a fast or easy process, especially when clinical trials and approvals are needed.
The leadership team has achieved and done this before with a previous business. The only difference this time is they are going global, so expect a few hiccups along the way and time restraints.
Original video for ASX listing is good to watch and see that the company has stayed true on the same path from day one." Spending money to commercialize products, open more markets, research and development , along with business development"
GMV Price at posting:
21.5¢ Sentiment: None Disclosure: Not Held
